Molecular mechanisms of tazarotene action in psoriasis

Journal of the American Academy of Dermatology

Volumn 37, Issue 2 III SUPPL., 1997, Pages

  Duvic, M ^a   Nagpal, S ^a   Asano, A T ^a   Chandraratna, R A S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID X RECEPTOR; TAZAROTENE;

ANTIINFLAMMATORY ACTIVITY; CELL PROLIFERATION; CONFERENCE PAPER; DOWN REGULATION; DRUG EFFECT; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS;

EID: 0030854635     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(97)80396-9     Document Type: Conference Paper

References (33)

1. JT Elder RP Nair S-W Guo The genetics of psoriasis Arch Dermatol 130 1994 216 224
2. GG Krueger M Duvic Epidemiology of psoriasis: clinical issues J Invest Dermatol 102 1994 14S 18S
3. WG Phillips SM Breathnach Psoriasis: immune indicators and treatment Clin Immunother 1 1994 157 167
4. MW Greaves GD Weinstein Treatment of psoriasis N Engl J Med 332 1995 581 588
5. T Henseler E Christophers Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris J Am Acad Dermatol 13 1985 450 456
6. W-H Boencke D Dressel TM Zollner R Kaufmann Pulling the trigger on psoriasis Nature 379 1996 777
7. JN Mansbridge AM Knapp Changes in keratinocyte maturation during wound healing J Invest Dermatol 89 1987 253 263
8. NV Konstantinova D-MT Duong E Remenyik P Hazarika A Chuang M Duvic IL-8 is induced in skin equivalents and is highest in those derived from psoriatic keratinocytes J Invest Dermatol 107 1996 613 621
9. BA Bernard D Asselineau L Schaffar-Deshayes Abnormal sequence of expression of differentiation markers in psoriatic epidermis: inversion of two steps in the differentiation program? J Invest Dermatol 90 1988 801 805
10. WT Schroeder SM Thacher S Stewart-Galetka Type I keratinocyte transglutaminase: expression in human skin and psoriasis J Invest Dermatol 99 1992 27 34
11. P Madsen HH Rasmussen H Leffers Molecular cloning occurrence, and expression of a novel partially secreted protein psoriasin that is highly up-regulated in psoriatic skin J Invest Dermatol 97 1991 701 712
12. K Nonomura K Yamanishi Y Hosokawa Localization of transglutaminase I mRNA in normal and psoriatic epidermis by non-radioactive in situ hybridization Br J Dermatol 128 1993 23 28
13. J Schalkwijk IMJJ van Vlihmen JAC Alkemade Immunohistochemical localization of SKALP/elafin in psoriatic epidermis J Invest Dermatol 100 1993 390 393
14. M Thaler K Fukuyama WL Epstein Comparative studies of keratins isolated from psoriasis and atopic dermatitis J Invest Dermatol 75 1980 156 158
15. M Thewes R Stadler B Korge Normal psoriatic epidermis expression of hyperproliferation-associated keratins Arch Dermatol Res 283 1991 465 471
16. M Sticherling E Bornscheuer JM Schroder E Christophers Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin J Invest Dermatol 96 1991 26 30
17. T Terui S Aiba T Kato HLA-DR antigen expression on keratinocytes in highly inflamed parts of psoriatic lesions Br J Dermatol 116 1987 87 93
18. AB Gottlieb B Lifshitz SM Fu Expression of HLA-DR molecules by keratinocytes, and presence of langerhans cells in the dermal infiltrate of active psoriatic plaques J Exp Med 164 1986 1013 1028
19. JT Elder DJ Fisher PB Lindquist Overexpression of transforming growth factor γ in psoriatic epidermis Science 243 1989 811 814
20. 125I] epidermal growth factor binding and receptor distribution in psoriasis J Invest Dermatol 86 1986 260 265
21. S Nagpal RAS Chandraratna Retinoids as anti-cancer agents Curr Pharmaceut Design 2 1996 295 316
22. MR Boehm RA Heyman S Patel RB Stein S Nagpal Retinoids: biological function and use in the treatment of dermatological diseases Exp Opin Invest Drugs 4 1995 593 612
23. S Nagpal J Athanikar RAS Chandraratna Separation of transactivation and AP1 antagonism functions of retinoic acid receptor α J Biol Chem 270 1995 923 927
24. GJ Fisher HS Talwar J-H Xiao Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin J Biol Chem 269 1994 20629 20635
25. JT Elder GJ Fisher QY Zhang Retinoic acid receptor gene expression in human skin J Invest Dermatol 96 1991 425 433
26. T Esgleyes-Ribot RA Chandraratna DA Lew-Kaya Response of psoriasis to a new topical retinoid AGN 190168 J Am Acad Dermatol 30 1994 581 590
27. GD Weinstein GG Krueger NJ Lowe Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect J Am Acad Dermatol 37 1997 85 92
28. S Nagpal S Patel AT Asano Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin J Invest Dermatol 106 1996 269 274
29. AT Asano S Nagpal RAS Chandraratna Tazarotene (AGN 190168), a topical retinoid, improves psoriasis and alters epidermal gene expression in vivo (Abstract) J Invest Dermatol 194 1995 694
30. Nagpal S, Patel S, Friant S, et al. Negative regulation of two hyperproliferative keratinocyte differentiation markers by an RAR-selective retinoid: insight into the mechanism of retinoid action in psoriasis. Cell Growth Differ. In press.
31. CEM Griffiths JJ Voorhees BJ Nickoloff Character-ization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor J Am Acad Dermatol 20 1989 617 629
32. Nagpal S. Tazarotene induced gene 2 (TIG-2), a novel retinoid responsive gene in skin. J Invest Dermatol. In press.
33. R Marks Early clinical development of tazarotene Br J Dermatol 135 suppl 49 1996 26 31